What is the maximum recommended dose of Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Trelegy Ellipta

The maximum recommended dose of Trelegy Ellipta is one inhalation of fluticasone furoate/umeclidinium/vilanterol 200/62.5/25 mcg once daily 1.

Dosing by Indication

For COPD

  • Single dose only: Fluticasone furoate/umeclidinium/vilanterol 100/62.5/25 mcg once daily
  • This is both the recommended and maximum dose for COPD patients 1

For Asthma

Adults (≥18 years):

  • Starting dose: 100/62.5/25 mcg once daily
  • Maximum dose: 200/62.5/25 mcg once daily 1
  • Escalate to the higher dose if inadequate response to 100/62.5/25 mcg
  • If inadequate response persists on 200/62.5/25 mcg, re-evaluate and consider alternative therapeutic regimens 1

Adolescents (12-17 years):

  • Fixed dose: 100/62.5/25 mcg once daily (this is the maximum for this age group) 1

Children (5-11 years):

  • Fixed dose: 50/62.5/25 mcg once daily (this is the maximum for this age group) 1

Critical Safety Warnings

Do not exceed one inhalation per 24 hours 1. The FDA label explicitly states that more frequent administration or a greater number of inhalations than prescribed is not recommended, as some patients are more likely to experience adverse effects with higher doses 1.

Common Pitfalls to Avoid:

  • Never use more than once daily - this is a once-daily medication only
  • Never double-dose if a dose is missed
  • Never use for acute bronchospasm - this is maintenance therapy only 1
  • Patients should rinse mouth after inhalation to reduce risk of oropharyngeal candidiasis 1

The evidence from real-world studies 2, 3 confirms that these FDA-approved doses are well-tolerated and effective when used as directed, with no safety signals suggesting benefit from exceeding the maximum recommended doses.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.